28 related articles for article (PubMed ID: 27432891)
1. FOXN3 controls liver glucose metabolism by regulating gluconeogenic substrate selection.
Karanth S; Chaurasia B; Bowman FM; Tippetts TS; Holland WL; Summers SA; Schlegel A
Physiol Rep; 2019 Sep; 7(18):e14238. PubMed ID: 31552709
[TBL] [Abstract][Full Text] [Related]
2. Hepatic ZBTB22 promotes hyperglycemia and insulin resistance via PEPCK1-driven gluconeogenesis.
Liu N; Yang X; Guo J; Zhang L; Huang S; Chen J; Huang J; Chen Y; Cui T; Zheng Y; Li T; Tang K; Zhong Y; Duan S; Yu L; Tang Y; Zheng D; Pan H; Gao Y
EMBO Rep; 2023 Jun; 24(6):e56390. PubMed ID: 37154299
[TBL] [Abstract][Full Text] [Related]
3. Modeling MEN1 with Patient-Origin iPSCs Reveals GLP-1R Mediated Hypersecretion of Insulin.
Cheng Z; Guo D; Ruzi A; Pan T; You K; Chen Y; Huang X; Zhang J; Yang F; Niu L; Xu K; Li YX
Cells; 2022 Aug; 11(15):. PubMed ID: 35954231
[TBL] [Abstract][Full Text] [Related]
4. A MEN1 pancreatic neuroendocrine tumour mouse model under temporal control.
Lines KE; Vas Nunes RP; Frost M; Yates CJ; Stevenson M; Thakker RV
Endocr Connect; 2017 May; 6(4):232-242. PubMed ID: 28420716
[TBL] [Abstract][Full Text] [Related]
5. Genetic background influences tumour development in heterozygous Men1 knockout mice.
Lines KE; Javid M; Reed AAC; Walls GV; Stevenson M; Simon M; Kooblall KG; Piret SE; Christie PT; Newey PJ; Mallon AM; Thakker RV
Endocr Connect; 2020 May; 9(5):426-437. PubMed ID: 32348957
[TBL] [Abstract][Full Text] [Related]
6. Glucose Activates Vagal Control of Hyperglycemia and Inflammation in Fasted Mice.
Joseph B; Shimojo G; Li Z; Thompson-Bonilla MDR; Shah R; Kanashiro A; Salgado HC; Ulloa L
Sci Rep; 2019 Jan; 9(1):1012. PubMed ID: 30700738
[TBL] [Abstract][Full Text] [Related]
7. Lithium and exercise ameliorate insulin-deficient hyperglycemia by independently attenuating pancreatic α-cell mass and hepatic gluconeogenesis.
Jung SR; Lee JH; Ryu H; Gao Y; Lee J
Korean J Physiol Pharmacol; 2024 Jan; 28(1):31-38. PubMed ID: 38154962
[TBL] [Abstract][Full Text] [Related]
8. MEN1 deficiency leads to neuroendocrine differentiation of lung cancer and disrupts the DNA damage response.
Qiu H; Jin BM; Wang ZF; Xu B; Zheng QF; Zhang L; Zhu LY; Shi S; Yuan JB; Lin X; Gao SB; Jin GH
Nat Commun; 2020 Feb; 11(1):1009. PubMed ID: 32081882
[TBL] [Abstract][Full Text] [Related]
9. Glucagon, a key factor in the pathophysiology of type 2 diabetes.
Girard J
Biochimie; 2017 Dec; 143():33-36. PubMed ID: 29024725
[TBL] [Abstract][Full Text] [Related]
10. The key role of islet dysfunction in type II diabetes mellitus.
Porte D; Kahn SE
Clin Invest Med; 1995 Aug; 18(4):247-54. PubMed ID: 8549009
[TBL] [Abstract][Full Text] [Related]
11. Male Men1 heterozygous mice exhibit fasting hyperglycemia in the early stage of MEN1.
Gao Z; Zhang L; Xie W; Wang S; Bao X; Guo Y; Zhang H; Hu Q; Chen Y; Wang Z; Xue M; Jin G
J Endocrinol; 2016 Sep; 230(3):347-55. PubMed ID: 27432891
[TBL] [Abstract][Full Text] [Related]
12. Heterozygous Men1 mutant mice develop a range of endocrine tumors mimicking multiple endocrine neoplasia type 1.
Bertolino P; Tong WM; Galendo D; Wang ZQ; Zhang CX
Mol Endocrinol; 2003 Sep; 17(9):1880-92. PubMed ID: 12819299
[TBL] [Abstract][Full Text] [Related]
13. Accelerated proliferation and differential global gene expression in pancreatic islets of five-week-old heterozygous Men1 mice: Men1 is a haploinsufficient suppressor.
Lejonklou MH; Barbu A; Stålberg P; Skogseid B
Endocrinology; 2012 Jun; 153(6):2588-98. PubMed ID: 22492302
[TBL] [Abstract][Full Text] [Related]
14. Haploinsufficient and predominant expression of multiple endocrine neoplasia type 1 (MEN1)-related genes, MLL, p27Kip1 and p18Ink4C in endocrine organs.
Taguchi R; Yamada M; Horiguchi K; Tomaru T; Ozawa A; Shibusawa N; Hashimoto K; Okada S; Satoh T; Mori M
Biochem Biophys Res Commun; 2011 Nov; 415(2):378-83. PubMed ID: 22037578
[TBL] [Abstract][Full Text] [Related]
15. Somatostatin receptor subtype-2-deficient mice with diet-induced obesity have hyperglycemia, nonfasting hyperglucagonemia, and decreased hepatic glycogen deposition.
Singh V; Grötzinger C; Nowak KW; Zacharias S; Göncz E; Pless G; Sauer IM; Eichhorn I; Pfeiffer-Guglielmi B; Hamprecht B; Wiedenmann B; Plöckinger U; Strowski MZ
Endocrinology; 2007 Aug; 148(8):3887-99. PubMed ID: 17525126
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
